The role of fluoride in the prevention of osteoporosis (Q40850937)

24 September 2017

1 reference

title

The role of fluoride in the prevention of osteoporosis (English)

1 reference

24 September 2017

0 references

M. Kleerekoper

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC:MED AND EXT_ID:9669148

31 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9669148

31 December 2024

publication date

1 June 1998

1 reference

24 September 2017

June 1998

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9669148

full work available at URL

31 December 2024

https://api.elsevier.com/content/article/PII:S0889852905700153?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

https://api.elsevier.com/content/article/PII:S0889852905700153?httpAccept=text/plain

31 December 2024

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

Endocrinology and Metabolism Clinics of North America

31 December 2024

published in

1 reference

24 September 2017

volume

27

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

441-452

1 reference

The effects of fluoride on osteoblast progenitors in vitro

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

INDUCTION OF SUBACUTE SKELETAL FLUOROSIS IN A CASE OF MULTIPLE MYELOMA

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Osteomalacia developing during treatment of osteoporosis with sodium fluoride and vitamin D

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Hip Fractures and Fluoridation in Utah's Elderly Population

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Responders and non-responders after fluoride therapy in osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Fluoride therapy for osteoporosis: characterization of the skeletal response by serial measurements of serum alkaline phosphatase activity

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Abnormal bone mineralization after fluoride treatment in osteoporosis: A small-angle x-ray-scattering study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Bilateral fractures of femoral neck in patients with moderate renal failure receiving fluoride for spinal osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Summary of workshop on drinking water fluoride influence on hip fracture on bone health. (National Institutes of Health, 10 April, 1991)

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Fluoride reduces the rate of dissolution of bone

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3 years) study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

In vitro release and in vivo serum fluoride levels and urinary excretion after different sodium fluoride tablets

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

How can we tell if a treatment works? Further thoughts on the randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

The response of vertebral bone mineral density during the treatment of osteoporosis with sodium fluoride.

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Effect of combined therapy with sodium fluoride, vitamin D and calcium in osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Effect of concurrent calcium ingestion on intestinal absorption of fluoride

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

The diagnosis of osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Fluorides and osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

A randomized trial of sodium fluoride as a treatment for postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Fluoride and the skeleton

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

A proposed mechanism of the mitogenic action of fluoride on bone cells: inhibition of the activity of an osteoblastic acid phosphatase

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

The effect of prolonged fluoride therapy for osteoporosis: bone composition and histology

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Risk-benefit ratio of sodium fluoride treatment in primary vertebral osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Fluoride and vertebral fractures

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Attainment of therapeutic fluoride levels in serum without major side effects using a slow-release preparation of sodium fluoride in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Safe and effective treatment of osteoporosis with intermittent slow release sodium fluoride: augmentation of vertebral bone mass and inhibition of fractures

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Comparison of nonrandomized trials with slow-release sodium fluoride with a randomized placebo-controlled trial in postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Effect of Sodium Fluoride on Calcium Metabolism of Human Beings

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Incidence of hip fractures in osteoporotic women treated with sodium fluoride

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Monofluorophosphate increases lumbar bone density in osteopenic patients: A double-masked randomized study

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

The increase in spinal bone density that occurs in response to fluoride therapy for osteoporosis is not maintained after the therapy is discontinued

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Designing clinical trials of treatment for osteoporosis: recruitment and follow-up

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

7 January 2021

Comparative study of fluoride bioavailability following the administration of sodium fluoride alone and in combination with different calcium salts

4

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

Bioavailability of enteric-coated sodium fluoride tablets as affected by the administration of calcium supplements at different time intervals

31 December 2024

12

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

Fluoride pharmacokinetics in good and poor responders to fluoride therapy

31 December 2024

39

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

The use of sodium fluoride, vitamin D and calcium supplements in the treatment of patients with axial osteoporosis

31 December 2024

56

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

A prospective study of bone mineral content and fracture in communities with differential fluoride exposure

31 December 2024

70

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

Effect of gastric contents on the bioavailability of fluoride in humans

31 December 2024

72

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

New approach to the treatment of bone disease with fluoride

31 December 2024

74

1 reference

https://api.crossref.org/works/10.1016/S0889-8529(05)70015-3

31 December 2024

Identifiers

1 reference

24 September 2017

1 reference